LASSBio-1911

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameLASSBio-1911
Drug Alias NameLASSBio-1911
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 8 inhibitorsHistone deacetylase 6 inhibitors
TargetsHistone deacetylase 6Histone deacetylase 8
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBrazil
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFederal University of Rio de Janeiro
China Registration ClassN/A

Develop Information

Active CompaniesFederal University of Rio de Janeiro
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A